RPS6KA1 explained

Ribosomal protein S6 kinase alpha-1 is an enzyme that in humans is encoded by the RPS6KA1 gene.[1]

Function

This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 nonidentical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.[2]

Interactions

RPS6KA1 has been shown to interact with:

See also

Further reading

Notes and References

  1. Moller DE, Xia CH, Tang W, Zhu AX, Jakubowski M . Human rsk isoforms: cloning and characterization of tissue-specific expression . The American Journal of Physiology . 266 . 2 Pt 1 . C351–9 . Feb 1994 . 8141249 . 10.1152/ajpcell.1994.266.2.C351.
  2. Web site: Entrez Gene: RPS6KA1 ribosomal protein S6 kinase, 90kDa, polypeptide 1.
  3. Schouten GJ, Vertegaal AC, Whiteside ST, Israël A, Toebes M, Dorsman JC, van der Eb AJ, Zantema A . IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase . The EMBO Journal . 16 . 11 . 3133–44 . Jun 1997 . 9214631 . 1169932 . 10.1093/emboj/16.11.3133 .
  4. Roux PP, Richards SA, Blenis J . Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity . Molecular and Cellular Biology . 23 . 14 . 4796–804 . Jul 2003 . 12832467 . 162206 . 10.1128/mcb.23.14.4796-4804.2003.
  5. Eblen ST, Kumar NV, Shah K, Henderson MJ, Watts CK, Shokat KM, Weber MJ . Identification of novel ERK2 substrates through use of an engineered kinase and ATP analogs . The Journal of Biological Chemistry . 278 . 17 . 14926–35 . Apr 2003 . 12594221 . 10.1074/jbc.M300485200 . free .
  6. Smith JA, Poteet-Smith CE, Malarkey K, Sturgill TW . Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo . The Journal of Biological Chemistry . 274 . 5 . 2893–8 . Jan 1999 . 9915826 . 10.1074/jbc.274.5.2893. free .
  7. Suzuki T, Matsuda S, Tsuzuku JK, Yoshida Y, Yamamoto T . A serine/threonine kinase p90rsk1 phosphorylates the anti-proliferative protein Tob . Genes to Cells . 6 . 2 . 131–8 . Feb 2001 . 11260258 . 10.1046/j.1365-2443.2001.00406.x. free .
  8. Roux PP, Ballif BA, Anjum R, Gygi SP, Blenis J . Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase . Proceedings of the National Academy of Sciences of the United States of America . 101 . 37 . 13489–94 . Sep 2004 . 15342917 . 518784 . 10.1073/pnas.0405659101 . 2004PNAS..10113489R . free .
  9. Rolfe M, McLeod LE, Pratt PF, Proud CG . Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2) . The Biochemical Journal . 388 . Pt 3 . 973–84 . Jun 2005 . 15757502 . 1183479 . 10.1042/BJ20041888 .
  10. Cavet ME, Lehoux S, Berk BC . 14-3-3beta is a p90 ribosomal S6 kinase (RSK) isoform 1-binding protein that negatively regulates RSK kinase activity . The Journal of Biological Chemistry . 278 . 20 . 18376–83 . May 2003 . 12618428 . 10.1074/jbc.M208475200 . free .